D-0655-2021 Class III Terminated

Recalled by Partner Therapeutics Inc — Lynnwood, WA

Recall Details

Product Type
Drugs
Report Date
July 21, 2021
Initiation Date
June 23, 2021
Termination Date
February 7, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
32,260 vials

Product Description

LEUKINE (Sargramostim) for Injection, 250 mcg/ vial, 5mL vials, 5 (250 mcg vials) per box, Rx only, Mfd by Partner Therapeutics, Inc. Lexington, MA 02421, NDC 71837-5843-5

Reason for Recall

FAILED STABILITY SPECIFICATION: Out-of-specification (OOS) result observed for Leukine (sargramostim) at the 27-month stability timepoint.

Distribution Pattern

Product was distributed to one government account (ASPR)

Code Information

Lot #: E8023E, exp. date 11/30/2022